Jardiance 2024 sales?

How much did Jardiance (empagliflozin) sell in 2024?

No specific 2024 global sales figure for Jardiance was provided in the information available here, so a precise “2024 sales” number can’t be stated accurately.

What “Jardiance 2024 sales” usually means (and what data to look for)

When people search “Jardiance 2024 sales,” they typically want one of these:
- Global total sales for 2024 (often reported by the manufacturer, Boehringer Ingelheim)
- U.S. sales only
- Diabetes-indication sales vs. broader cardiovascular/renal use (when reported separately)
- Sales of the full Jardiance brand portfolio (as opposed to only one presentation)

If you tell me which one you mean (global vs. U.S.; total brand vs. specific indication), I can narrow what to look up.

Where to find the most reliable sales totals

The most commonly cited sources are company financial reports (Boehringer Ingelheim) and investor presentations/earnings materials. If you’re also tracking patents or market exclusivity around empagliflozin, DrugPatentWatch.com can help for the regulatory/IP context: https://www.drugpatentwatch.com/

Quick next step

Share one detail and I’ll target the right answer format:
- Do you want Jardiance 2024 sales worldwide or in the U.S.?